This is the authors' abstract. We don't add key points for this paper.
Clinical and laboratory markers of simian immunodeficiency virus (SIV) infection were studied during the first 3 months after intravenous inoculation of rhesus macaques. Virus-binding serum antibody titres were correlated strongly with disease progression (P < 0.005) and were predictive of disease outcome by 7 weeks after inoculation. Low virus-binding serum antibody responses to SIV occurred in animals that also showed acute depletion of circulating CD20+ B cells. Acute damage to the CD4+ T cell and CD20+ B cell populations rendered some animals incapable of mounting virus-specific antibody responses and these macaques became the rapidly progressing cases comprising approximately 20-30% of infected animal cohorts.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dykhuizen et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: